Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2004Alimentary Pharmacology & TherapeuticsOpen Access

The safe threshold for gluten contamination in gluten‐free products. Can trace amounts be accepted in the treatment of coeliac disease?

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPekka CollinUniversity of GenevaLTLars‐Håkan ThorellLinköping UniversityKKKatri KaukinenTampere University of Applied Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Collin et al. (2004) studied this question.

synapsesocial.com/papers/6a701fa178a11c550e09f173https://doi.org/10.1111/j.1365-2036.2004.01961.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Very late mucosal relapse in a girl with coeliac disease1993 · 14 citations
  2. 2Endomysium antibodies in coeliac disease: an improved method.1994 · 291 citations
  3. 3Even Small Amounts of Gluten Cause Relapse in Children With Celiac Disease2002 · 51 citations
  4. 4Persistent Mucosal Abnormalities in Coeliac Disease Are Not Related to the Ingestion of Trace Amounts of Gluten1999 · 69 citations
  5. 5Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.1993 · 133 citations